ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Topical Vancomycin and Risk of Sternal Wound Infections: A Double-Blind Randomized Controlled Trial

Friday, October 28, 2022

Submitted by

Cameron Lind

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://doi.org/10.1016/j.athoracsur.2021.11.012

Author(s)

Maria Servito, BHSc, Abbas Khani-Hanjani, MD, Kayla-Marie Smith, BS, Ross T. Tsuyuki, PharmD, MS, and John C. Mullen, MD

A study was performed to assess the efficacy of topical vancomycin in the reduction of sternal wound infection (SWI), as this topic has become a point of contention. There was no difference between the vancomycin and saline control group at three months postoperatively, and similar findings were observed at one year. The study concluded that applying vancomycin makes no significant difference in SWI.